INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
30/10/2025
Voltar para busca
Dado oficial do USPTO
PASYLATION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PASYLATION
ST13
US500000079126686Classe
1, 5, 42
Pedido
79126686
Registro
4483086
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
56
Atualização mais recente
31/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
17/10/2012
Data de registro
18/02/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/10/2024
Última transação
31/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
Freising, DE
Examinador
BEVERLY,JOSETTE MICHELLE
Localização atual
Historical data usage
Titulares e representantes
Titulares
XL-protein GmbH
XL-protein GmbH
Representantes
Anthony G. Craig Sci-Law Strategies, PC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals and biochemicals for research and laboratory purposes excluding for medical or veterinary purposesfor industrial and scientific purposes; unprocessed artificial resinsunprocessed plastics; chemical and biological preparations for medical research and medical and scientific purposes
Classe 5
Pharmaceutical and veterinary preparations and preparations for human medical purposes for use in treating growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; sanitary preparations for medical purposes; dietetic substances adapted for medical usenutritional supplements containing proteinspeptidesfood for babies; preparations for destroying vermin; fungicidesherbicides; pharmaceutical and diagnostic preparations for medicaldental and forensic purposes and for purposes of forensic medicine and laboratory medicinepharmaceutical and diagnostic preparations for diagnosispreventiontreatment or cure of growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; testing reagents in kit form for medicaldental and forensic purposes and for purposes of forensic medicine and laboratory medicinemedical and forensic diagnostic reagents and assays for testing of body tissues and body fluids; chemical and biotechnological preparations for medical and diagnostic purposesreagents and solvents for sample preparationmodification and manipulation of cells and for performing of markingseparationisolationpurificationamplification and/or analytical methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes included in this class; medicaments for preventivecurative and palliative purposes for preventingtreating or curing of growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; medical biomarkersin particular for preventativediagnosticprognostic or predictive purposespolypeptide sequences; medical preparationskits for laboratory medicine in particular for preventivediagnosticprognostic or predictive purposesdiagnostic kits consisting primarily of proteinsbuffersreagents for use in detecting growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; biomolecules for medical purposesproteinspeptides and small molecule drugs with conjugated polypeptide sequences for binding of active substances; medical preparations for analytical purposesreagents for detecting growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; preparations for health carefor diagnosispreventiontreatmentcure of growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases
Classe 42
Scientific and technological services and researchscientific researchanalysistestingin the fields of chemistrygeneticsbiologybiotechnology and biochemistry; technical servicescomputer diagnostic services in the field of DNARNA and protein expressiondetection and analysis and respective design servicesin particular in the fields of chemistrygeneticsbiologybiotechnology and biochemistry; industrial analysis and research services in the field of medicaldentalforensic and scientific research; design and development of computer hardware and software; services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations; and preparation of scientific opinions; quality checkingquality evaluation services for the medical and pharmaceutical industry; design and development of programs for data processing; consultancy for scientificlaboratory and research purposes in the field of chemistrygeneticsbiologybiotechnology and biochemistry; scientific services of a technical measuring and test laboratory; technological consulting services pertaining to scientific and industrial scientific research in the fields of generationtechnical processing and technical analysis of biomaterials and medically relevant data
Publicações
Histórico de despachos e eventos da marca no USPTO.
56 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/06/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/10/2024
71AG
REGISTERED-SEC.71 ACCEPTED
07/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/10/2024
ES71
TEAS SECTION 71 RECEIVED
12/02/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
18/02/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
04/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2022
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
09/09/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
29/08/2021
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
13/02/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/01/2021
INPC
INVALIDATION PROCESSED
31/12/2020
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
29/12/2020
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
29/12/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
27/12/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/10/2020
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
12/05/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/04/2020
ES75
TEAS SECTION 71 & 15 RECEIVED
18/02/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/02/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/02/2020
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
18/02/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/07/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/06/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/06/2014
FIMP
FINAL DISPOSITION PROCESSED
06/06/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/05/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
18/02/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2013
PUBO
PUBLISHED FOR OPPOSITION
03/12/2013
GPNX
NOTIFICATION PROCESSED BY IB
02/12/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/11/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
13/11/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/11/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
30/10/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/10/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/09/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/09/2013
ALIE
ASSIGNED TO LIE
20/09/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/09/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/09/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/09/2013
RFNT
REFUSAL PROCESSED BY IB
23/04/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/03/2013
RFRR
REFUSAL PROCESSED BY MPU
28/03/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/03/2013
CNRT
NON-FINAL ACTION WRITTEN
27/03/2013
MAFR
APPLICATION FILING RECEIPT MAILED
22/03/2013
DOCK
ASSIGNED TO EXAMINER
18/03/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/03/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/03/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PASYLATION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.